Lili Ye
Finanzdirektor/CFO bei LONGWEN GROUP CORP.
Vermögen: 1 Mio $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Lili Ye
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Capital Normal University
4
| College/University | Other Consumer Services | 4 |
| Public Company | Financial Conglomerates | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lili Ye
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PEACE MAP HOLDING LIMITED | Information Technology Services | Chief Executive Officer | |
Beijing Peace Map Information & Technology Ltd.
 Beijing Peace Map Information & Technology Ltd. Engineering & ConstructionIndustrial Services Part of Peace Map Holding Ltd., Beijing Peace Map Information & Technology Ltd. provides aerial photography, aviation remote sensing processing, and software publication services. Zheng Wang has been the CEO of the Chinese company since 2012. | Engineering & Construction | Chief Executive Officer | |
| Wuhan University | College/University | Undergraduate Degree | |
| University of Tokyo | College/University | Graduate Degree | |
| Tsinghua University | College/University | Masters Business Admin | |
Peace Map Co., Ltd.
 Peace Map Co., Ltd. Engineering & ConstructionIndustrial Services Part of Peace Map Holding Ltd., Peace Map Co., Ltd. provides aerial photography, aviation remote sensing, and software publication services. The company is based in Beijing, China. | Engineering & Construction | Chairman | |
| WO GROUP, INC. | Financial Conglomerates | Chief Executive Officer | |
| Zhejiang Longwen Investment Management Co. , Ltd. | President | ||
| Hangzhou Longwen Culture & Media Co. , Ltd. | Chief Executive Officer | ||
| Beijing Humanities University | College/University | Undergraduate Degree | |
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| Capital University of Economics & Business | College/University | Undergraduate Degree | |
| SINO BIOLOGICAL,INC. | Pharmaceuticals: Major | Director/Board Member | |
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistik
International
| China | 11 |
| Hong Kong | 3 |
| Japan | 2 |
| Vereinigte Staaten | 2 |
Sektoral
| Consumer Services | 6 |
| Industrial Services | 3 |
| Health Technology | 3 |
| Technology Services | 2 |
| Finance | 2 |
Operativ
| Chief Executive Officer | 5 |
| Undergraduate Degree | 5 |
| Director/Board Member | 4 |
| Chairman | 3 |
| President | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Hong Liang Guan | 7 |
| Xi Zhen Ye | 5 |
| Qi Li | 3 |
| Ran Gao | 2 |
| Xiao Ni Zhang | 2 |
